ABT · Abbott Laboratories

$104.49 +3.74 (+3.71%) At close · Jul 27

Market Cap

$182.00B

1.74B

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Robert Ford	CEO	$1,500,000	—	$8,787,378	$8,788,430	$1,968,750	$959,798	$24,198,660
Philip Boudreau	CFO	$974,231	—	$3,045,935	$3,046,350	$1,055,400	$74,418	$9,090,636
Lisa D. Earnhardt	Executive Vice President and Group President, Medical Devices	$924,231	—	$2,543,989	$2,544,364	$1,283,400	$178,953	$8,069,724
Hubert L. Allen	General Counsel	$524,019	—	$2,095,392	$2,095,609	$447,500	$653,224	$6,995,583
Christopher J. Scoggins	Executive Vice President, Diabetes Care	$859,502	—	$1,662,503	$1,662,743	$1,095,300	$108,443	$6,601,667
Daniel G. Salvadori	Executive Vice President and Group President, Established Pharmaceuticals and Nutritional Products	$924,231	—	$2,238,786	$2,239,049	$388,200	$212,501	$6,534,285

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Robert Ford	CEO	$1,500,000	—	$8,226,593	$8,227,441	$2,861,250	$618,998	$22,777,075
Robert Funck	Executive Vice President, Finance, and Chief Financial Officer	$535,096	—	$2,867,938	$2,868,225	$564,000	$553,057	$8,257,928
Philip Boudreau	CFO	$884,039	—	$2,693,071	$2,693,336	$1,224,700	$74,748	$8,225,746
Hubert L. Allen	General Counsel	$911,154	—	$2,095,365	$2,095,609	$1,094,700	$540,170	$7,981,335
Lisa D. Earnhardt	Executive Vice President and Group President, Medical Devices	$879,269	—	$2,016,528	$2,016,819	$1,249,200	$130,047	$6,558,461
Daniel G. Salvadori	Executive Vice President and Group President, Established Pharmaceuticals and Nutritional Products	$879,269	—	$1,833,239	$1,833,495	$855,400	$157,015	$5,789,762

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Robert Ford	CEO	$1,500,000	—	$7,436,600	$7,437,649	$2,945,250	$283,392	$23,268,171
Robert Funck	Executive Vice President, Finance, and Chief Financial Officer	$875,000	—	$2,593,908	$2,594,349	$1,062,100	$238,790	$8,992,208
Hubert L. Allen	General Counsel	$830,000	—	$1,959,639	$1,959,993	$941,700	$228,916	$7,420,660
Daniel G. Salvadori	Executive Vice President and Group President, Established Pharmaceuticals and Nutritional Products	$790,000	—	$1,880,183	$1,880,493	$880,300	$91,977	$5,934,830
Lisa D. Earnhardt	Executive Vice President and Group President, Medical Devices	$737,654	—	$1,684,197	$1,684,477	$904,900	$85,380	$5,498,436
Philip Boudreau	CFO	$513,943	—	$786,041	$786,272	$583,500	$44,083	$3,317,182

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Robert Ford	CEO	$1,500,000	—	$8,699,609	$8,699,985	$2,231,250	$321,722	$21,722,152
Robert Funck	Executive Vice President, Finance, and Chief Financial Officer	$866,154	—	$3,372,286	$3,372,494	$956,000	$341,718	$9,145,220
Daniel G. Salvadori	Executive Vice President and Group President, Established Pharmaceuticals and Nutritional Products	$790,000	—	$2,812,276	$2,812,489	$600,500	$96,812	$7,157,684
Hubert L. Allen	General Counsel	$817,615	—	$2,396,766	$2,396,850	$871,500	$322,031	$7,019,635
Andrea F. Wainer	Executive Vice President, Rapid and Molecular Diagnostics	$710,000	—	$2,230,633	$2,230,786	$906,300	$134,662	$6,287,118

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Robert Ford	CEO	$1,482,692	—	$8,689,294	$8,689,978	$3,168,400	$129,179	$24,914,886
Miles D. White	Chairman	$1,900,000	—	$5,499,490	$5,499,982	$0	$1,135,477	$15,953,084
Robert Funck	Executive Vice President, Finance, and Chief Financial Officer	$825,000	—	$2,999,666	$2,999,977	$1,048,400	$159,193	$9,539,309
Andrea F. Wainer	Executive Vice President, Rapid and Molecular Diagnostics	$699,616	—	$2,388,446	$2,388,734	$931,600	$69,112	$7,250,414
Hubert L. Allen	General Counsel	$760,000	—	$2,115,332	$2,115,612	$921,700	$172,158	$6,853,756
Daniel G. Salvadori	Executive Vice President and Group President, Established Pharmaceuticals and Nutritional Products	$715,539	—	$2,388,446	$2,388,734	$925,700	$72,276	$6,742,299

Fiscal 2020

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Robert Ford	CEO	$1,298,462	—	$5,623,995	$5,624,993	$3,675,000	$77,872	$20,450,586
Miles D. White	Chairman	$1,900,000	—	$5,998,934	$5,999,997	$1,250,000	$1,264,110	$19,828,384
Robert Funck	CFO	$813,462	—	$2,215,867	$2,216,247	$1,280,800	$173,568	$9,800,209
Hubert L. Allen	General Counsel	$751,346	—	$1,874,607	$1,874,988	$917,700	$154,596	$8,478,177
Daniel G. Salvadori	Executive Vice President and Group President, Established Pharmaceuticals and Nutritional Products	$710,000	—	$1,901,708	$1,902,099	$905,500	$79,421	$5,975,739

Fiscal 2019

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Miles D. White	Chairman	$1,900,000	—	$7,562,448	$7,562,499	$4,405,625	$664,409	$27,802,817
Robert Ford	CEO	$1,000,000	—	$3,475,992	$3,476,054	$1,562,500	$71,841	$11,897,886
Hubert L. Allen	General Counsel	$710,000	—	$2,199,962	$2,199,990	$879,700	$66,905	$7,486,080
Daniel G. Salvadori	Executive Vice President and Group President, Established Pharmaceuticals and Nutritional Products	$704,923	—	$2,351,989	$2,351,986	$903,400	$59,806	$6,767,814

Key facts CIK 1800 CUSIP 002824100 13F (30d) 962 filings 948 filers Visit website